Coronavirus nasal vaccine to be registered in 2022

The Head of the Center for Epidemiology and Microbiology named after Gamaleya Alexander Gunzburg said that clinical trials of a nasal vaccine against coronavirus will start in late 2021 or early 2022. The drug will probably be registered as early as next year.

"The center is working in several directions in terms of creating and improving vaccines against COVID-19. One direction is the creation of a nasal form of the vaccine. Its preclinical studies are now underway. We plan to enter the clinic at the end of this - beginning of next year, with the release of its registration according to the results of the study in 2022", - TASS quotes the words of Gunzburg.

Earlier, the scientist reported that while it is assumed that the introduction of the nasal vaccine developed at the Center, will be two times. However, Gunzburg did not rule out a single use of the drug. According to him, the advantage of this vaccine is that it will have virtually no side effects.

The fact that the Center. Gamalei patented an anti-clotting vaccine in the form of a spray for nome, it became known at the end of April. In addition, the Center has submitted another application for the use of the vaccine in a combined way - intranasal and intramuscular.